Admission Date:  [**2202-10-11**]              Discharge Date:   [**2202-10-20**]  Date of Birth:  [**2145-7-27**]             Sex:   F  Service: CARDIOTHORACIC  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1267**] Chief Complaint: Mitral and tricuspid regurgitation  Major Surgical or Invasive Procedure: [**2202-10-11**] - Redo Sternotomy, Mitral valve replacement(27mm St. [**Male First Name (un) 923**] Mechanical), tricuspid valve Repair(30mm CE Annuloplasty Ring)   History of Present Illness: Mrs. [**Known lastname 9996**] is a 57-year-old woman  who is five years status post bovine pericardial aortic valve replacement who presents with increasing mitral regurgitation, tricuspid regurgitation and hepatic enlargement.
It was elected to proceed with mitral valve replacement, tricuspid repair.
Past Medical History: mitral regurgitation tricuspid regurgitation s/p aortic valve replacement systemic lupus erythematosis systemic hypertension pulmonary hypertension raynaud's disease s/p cholecystectomy lupus nephritis rheumatic heart disease portal hypertension anemia  Social History: Patient is married with one son, denies tobacco, minimal EtOH   Family History: Grandmother died from a CVA at age 50.
A bioprosthetic aortic valve prosthesis is present.
Post Bypass The patient is AV-paced and on an infusion of epinephrine .04 mcg/kg/min.. Left and right ventricular function is preserved.
The mitral valve mechanical prosthesis is in good position with a mean gradient <6mmHg..
[**2202-10-19**] 05:30AM BLOOD WBC-14.1* RBC-2.77* Hgb-8.5* Hct-25.4* MCV-92 MCH-30.8 MCHC-33.5 RDW-16.4* Plt Ct-283 [**2202-10-20**] 10:50AM BLOOD PT-24.7* INR(PT)-2.4* [**2202-10-18**] 05:25AM BLOOD PT-40.7* PTT-36.2* INR(PT)-4.4* [**2202-10-18**] 01:35AM BLOOD PT-38.1* PTT-35.9* INR(PT)-4.1* [**2202-10-17**] 07:00PM BLOOD PT-60.6* PTT-35.9* INR(PT)-7.2* [**2202-10-17**] 04:58PM BLOOD PT-57.5* PTT-33.6 INR(PT)-6.8* [**2202-10-17**] 01:00PM BLOOD PT-49.3* PTT-35.9* INR(PT)-5.6* [**2202-10-17**] 06:35AM BLOOD PT-45.7* PTT-81.8* INR(PT)-5.1* [**2202-10-16**] 10:04AM BLOOD PT-20.1* PTT-55.1* INR(PT)-1.9* [**2202-10-16**] 03:45AM BLOOD PT-17.1* PTT-56.5* INR(PT)-1.5* [**2202-10-15**] 05:50AM BLOOD PT-16.9* PTT-50.2* INR(PT)-1.5* [**2202-10-14**] 04:33AM BLOOD PT-17.7* PTT-38.3* INR(PT)-1.6* [**2202-10-14**] 03:08AM BLOOD PT-18.7* PTT-104.1* INR(PT)-1.7*  Brief Hospital Course: Mrs. [**Known lastname 9996**] was admitted to the [**Hospital1 18**] on [**2202-10-11**] for elective surgical management of her mitral and triccuspid valve disease.
She was taken directly to the operating room where she underwent a redo sternotomy with a mitral valve replacement using a 27mm St. [**Male First Name (un) 923**] mechanical valve and a tricuspid valve repair/annuloplasty.
She weaned fro bypass on epinephrine and propafol.
Diuresis was continued, to remove fluid overload that existed preoperatively as well as secondary to the surgery.
The EPS service saw her and cardioversion was planned.
her INR was 2.4 the day of discharge and 2 mg of Coumadin was ordered.
Her weight fell with diuresis and edema improved.
She was ready for discharge and diuretics will be continued.
Arrangement were made for her follow-up for Coumadin dosing with her primary care physician [**Last Name (NamePattern4) **].
She will take 2mg [**10-20**] and 16 then have a PT/INR checked on[**10-22**] and talk with Dr. [**Last Name (STitle) **] for further orders.
Medications on Admission: lasix 20', plaquenil 200", lisinopril 40', lopressor 100", diovan 160', ASA 81', ferrex 150", MVI  Discharge Medications: 1.
Potassium Chloride 20 mEq Tab Sust.Rel.
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day) for 2 weeks.
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) for 2 weeks.
Aspirin 81 mg Tablet, Delayed Release (E.C.)
Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO Q4H (every 4 hours) as needed.
Hydroxychloroquine 200 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Multivitamin     Tablet Sig: One (1) Tablet PO DAILY (Daily).
Polysaccharide Iron Complex 150 mg Capsule Sig: One (1) Capsule PO bid ().
Tramadol 50 mg Tablet Sig: One (1) Tablet PO Q4H (every 4 hours) as needed for pain.
Percocet 5-325 mg Tablet Sig: 1-2 Tablets PO every four (4) hours as needed for pain for 4 weeks.
Warfarin 1 mg Tablet Sig: as directed Tablet PO Once Daily at 4 PM: [**Name8 (MD) **] MD for instructions as directed.
Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 40 mg Tablet Sig: One (1) Tablet PO twice a day.
Disp:*60 Tablet(s)* Refills:*2*   Discharge Disposition: Home With Service  Facility: [**Hospital 119**] Homecare  Discharge Diagnosis: s/p mitral valve replacement and tricuspid annuloplasty mitral regurgitation tricuspid regurgitation s/p aortic valve replacement hypertention Pulmonary hypertension systemic Lupus erythematosis H/O Rheumatic heart disease Raynaud's disease congestive heart failure Rheumatoid arthritis Esophagheal spasm Lupus nephritis Anemia Mild hepatic portal fibrosis s/p cholecystectomy   Discharge Condition: good   Discharge Instructions: 1)  Monitor wounds for signs of infection.
These include redness, drainage or increased pain.
4)  No lotions, creams or powders to incision until it has healed.
Phone:[**Telephone/Fax (1) 463**] Date/Time:[**2202-11-24**] 4:45 Provider: [**First Name11 (Name Pattern1) 177**] [**Last Name (NamePattern4) 2310**], MD Phone:[**Telephone/Fax (1) 2226**] Date/Time:[**2202-12-9**] 2:30 Provider: [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **], MD Phone:[**Telephone/Fax (1) 435**] Date/Time:[**2202-12-21**] 3:30  Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] in [**1-6**] weeks and for Coumadin dosing.
